Skinvisible, Inc. (SKVI) is the 287th largest of 300 Pharmaceuticals companies by market capitalisation, at 2.32 Mn, behind CASI Pharmaceuticals, Inc. at 2.60 Mn. The table below compares all 300 on 8 financial metrics.
| # | Ticker | Company | match | industry_code | industry_group | industry_group_code | Market Capitalization | P/E | P/S | Enterprise Value |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | JNJ | Johnson & Johnson | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 648.48 Bn | 30.83 | 0.00 Mn | 627.72 Bn |
| 2 | ABBV | AbbVie Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 441.05 Bn | 69.83 | 0.00 Mn | 434.48 Bn |
| 3 | MRK | Merck & Co., Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 367.88 Bn | 116.09 | 0.00 Mn | 360.74 Bn |
| 4 | NVS | Novartis Ag | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 267.37 Bn | 9.28 | 0.00 Mn | 259.68 Bn |
| 5 | PFE | Pfizer Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 158.57 Bn | 36.30 | 0.00 Mn | 146.88 Bn |
| 6 | SNY | Sanofi | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 52.75 Bn | 11.32 | 0.00 Mn | 45.36 Bn |
| 7 | RVMD | Revolution Medicines, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 43.75 Bn | -24.74 | — | 43.75 Bn |
| 8 | ONC | BeOne Medicines Ltd. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 39.12 Bn | 59.65 | 0.00 Mn | 34.02 Bn |
| 9 | INCY | Incyte Corp | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 25.04 Bn | 15.53 | 0.00 Mn | 20.51 Bn |
| 10 | UTHR | UNITED THERAPEUTICS Corp | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 21.24 Bn | 16.21 | 0.00 Mn | 18.58 Bn |
| 11 | NBIX | Neurocrine Biosciences Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 15.70 Bn | 22.25 | 0.00 Mn | 15.31 Bn |
| 12 | JAZZ | Jazz Pharmaceuticals plc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 15.15 Bn | 16.11 | 0.00 Mn | 13.53 Bn |
| 13 | EXEL | Exelixis, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 14.51 Bn | 16.86 | 0.00 Mn | 13.67 Bn |
| 14 | CORT | Corcept Therapeutics Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 11.96 Bn | 220.66 | 0.00 Mn | 11.65 Bn |
| 15 | KYMR | Kymera Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 11.44 Bn | -38.19 | 0.00 Mn | 10.75 Bn |
| 16 | AXSM | Axsome Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 10.73 Bn | -69.83 | 0.00 Mn | 10.42 Bn |
| 17 | CYTK | Cytokinetics Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 9.91 Bn | -13.51 | 0.00 Mn | 8.75 Bn |
| 18 | NUVL | Nuvalent, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 9.75 Bn | -27.07 | — | 9.75 Bn |
| 19 | CRNX | Crinetics Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 8.99 Bn | -17.90 | 0.00 Mn | 8.99 Bn |
| 20 | GPCR | Structure Therapeutics Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 8.89 Bn | -47.27 | — | 8.89 Bn |
| 21 | ALKS | Alkermes plc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 7.66 Bn | 115.82 | 0.00 Mn | 7.00 Bn |
| 22 | BLTE | Belite Bio, Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 6.42 Bn | 0.09 | — | 6.42 Bn |
| 23 | TVTX | Travere Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 6.18 Bn | -142.16 | 0.00 Mn | 6.06 Bn |
| 24 | LQDA | Liquidia Corp | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 6.02 Bn | 43.40 | 0.00 Mn | 5.73 Bn |
| 25 | AMRN | Amarin Corp Plc\Uk | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 5.89 Bn | -217.02 | 0.00 Mn | 5.57 Bn |
| 26 | ACAD | Acadia Pharmaceuticals Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.75 Bn | 12.49 | 0.00 Mn | 3.80 Bn |
| 27 | EWTX | Edgewise Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.71 Bn | -23.86 | — | 4.71 Bn |
| 28 | DFTX | Definium Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.22 Bn | -11.94 | — | 4.22 Bn |
| 29 | MANE | Veradermics, Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.19 Bn | -48.69 | — | 4.19 Bn |
| 30 | INDV | Indivior Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.09 Bn | 11.51 | 0.00 Mn | 3.86 Bn |
| 31 | ELVN | Enliven Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.93 Bn | -46.69 | — | 3.93 Bn |
| 32 | CPRX | CATALYST PHARMACEUTICALS, INC. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.85 Bn | 17.94 | 0.00 Mn | 3.09 Bn |
| 33 | TARS | Tarsus Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.80 Bn | -81.05 | 0.00 Mn | 3.35 Bn |
| 34 | OGN | Organon & Co. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.62 Bn | 17.30 | 0.00 Mn | 2.48 Bn |
| 35 | NAMS | NewAmsterdam Pharma Co N.V. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.16 Bn | -12.18 | 0.00 Mn | 3.16 Bn |
| 36 | TRVI | Trevi Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.63 Bn | -62.45 | — | 2.63 Bn |
| 37 | TAK | Takeda Pharmaceutical Co Ltd | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.62 Bn | 4.57 | 0.00 Mn | -3.18 Bn |
| 38 | MLYS | Mineralys Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.62 Bn | -7.50 | — | 2.62 Bn |
| 39 | SUPN | Supernus Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.47 Bn | -29.00 | 0.00 Mn | 2.10 Bn |
| 40 | HRMY | Harmony Biosciences Holdings, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.47 Bn | 13.82 | 0.00 Mn | 1.66 Bn |
| 41 | NUVB | Nuvation Bio Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.33 Bn | -21.54 | 0.00 Mn | 2.33 Bn |
| 42 | PVLA | Palvella Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.20 Bn | -41.56 | — | 1.89 Bn |
| 43 | AUPH | Aurinia Pharmaceuticals Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.10 Bn | 6.67 | 0.00 Mn | 1.65 Bn |
| 44 | ETON | Eton Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.64 Bn | 171.54 | 0.00 Mn | 1.61 Bn |
| 45 | INVA | Innoviva, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.56 Bn | 7.97 | 0.00 Mn | 0.98 Bn |
| 46 | LBRX | Lb Pharmaceuticals Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.48 Bn | -24.52 | — | 1.48 Bn |
| 47 | XERS | Xeris Biopharma Holdings, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.46 Bn | -85.08 | 0.00 Mn | 1.34 Bn |
| 48 | HROW | Harrow, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.42 Bn | -42.31 | 0.00 Mn | 1.33 Bn |
| 49 | OPK | Opko Health, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.20 Bn | -31.59 | 0.00 Mn | 0.90 Bn |
| 50 | OLMA | Olema Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.14 Bn | -5.59 | — | 1.14 Bn |
| 51 | KURA | Kura Oncology, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.11 Bn | -4.67 | 0.00 Mn | 1.11 Bn |
| 52 | PCRX | Pacira BioSciences, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.02 Bn | 69.47 | 0.00 Mn | 0.77 Bn |
| 53 | LXRX | Lexicon Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.97 Bn | -15.48 | 0.00 Mn | 0.78 Bn |
| 54 | SGP | SpyGlass Pharma, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.97 Bn | -48.72 | — | 0.97 Bn |
| 55 | DSGN | Design Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.95 Bn | -11.77 | — | 0.74 Bn |
| 56 | IVA | Inventiva S.A. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.87 Bn | 9.58 | 0.00 Mn | 0.87 Bn |
| 57 | VSTM | Verastem, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.81 Bn | -7.01 | 0.00 Mn | 0.67 Bn |
| 58 | PHAT | Phathom Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.79 Bn | -8.05 | 0.00 Mn | 0.61 Bn |
| 59 | COLL | Collegium Pharmaceutical, Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.76 Bn | 15.81 | 0.00 Mn | 0.61 Bn |
| 60 | ZVRA | Zevra Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.75 Bn | 12.83 | 0.00 Mn | 0.53 Bn |
| 61 | GYRE | Gyre Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.72 Bn | -39.05 | 0.00 Mn | 0.66 Bn |
| 62 | AQST | Aquestive Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.64 Bn | -8.24 | 0.00 Mn | 0.55 Bn |
| 63 | CRMD | CorMedix Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.64 Bn | 5.10 | 0.00 Mn | 0.38 Bn |
| 64 | MPLT | MapLight Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.63 Bn | -3.13 | — | 0.63 Bn |
| 65 | EOLS | Evolus, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.59 Bn | -17.17 | 0.00 Mn | 0.54 Bn |
| 66 | NVCT | Nuvectis Pharma, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.56 Bn | -18.54 | — | 0.56 Bn |
| 67 | OVID | Ovid Therapeutics Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.54 Bn | -15.71 | 0.00 Mn | 0.42 Bn |
| 68 | SPRY | ARS Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.54 Bn | -2.43 | 0.00 Mn | 0.39 Bn |
| 69 | PALI | Palisade Bio, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.46 Bn | -13.08 | 0.00 Mn | 0.34 Bn |
| 70 | XFOR | X4 Pharmaceuticals, Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.43 Bn | -4.77 | 0.00 Mn | 0.24 Bn |
| 71 | IKT | Inhibikase Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.43 Bn | -6.55 | — | 0.27 Bn |
| 72 | VTVT | vTv Therapeutics Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.41 Bn | -85.98 | 0.00 Mn | 0.41 Bn |
| 73 | TTRX | Turn Therapeutics Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.37 Bn | -47.65 | — | 0.37 Bn |
| 74 | ACHV | Achieve Life Sciences, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.34 Bn | — | — | 0.34 Bn |
| 75 | SION | Sionna Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.33 Bn | -3.42 | — | 0.33 Bn |
| 76 | VNDA | Vanda Pharmaceuticals Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.32 Bn | -1.17 | 0.00 Mn | 0.15 Bn |
| 77 | EBS | Emergent BioSolutions Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.31 Bn | -1.75 | 0.00 Mn | 0.17 Bn |
| 78 | IMRX | Immuneering Corp | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.31 Bn | -5.24 | — | 0.31 Bn |
| 79 | FULC | Fulcrum Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.29 Bn | -3.27 | — | 0.29 Bn |
| 80 | ZNTL | Zentalis Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.29 Bn | -2.05 | — | 0.29 Bn |
| 81 | AKBA | Akebia Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.28 Bn | -9.32 | 0.00 Mn | 0.12 Bn |
| 82 | CELG-RI | Bristol Myers Squibb Co | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.23 Bn | 0.03 | 0.00 Mn | -10.83 Bn |
| 83 | SIGA | Siga Technologies Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.23 Bn | — | — | 0.07 Bn |
| 84 | TNXP | Tonix Pharmaceuticals Holding Corp. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.22 Bn | -1.38 | 0.00 Mn | 0.22 Bn |
| 85 | DERM | Journey Medical Corp | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.22 Bn | -59.52 | 0.00 Mn | 0.19 Bn |
| 86 | ACOG | Alpha Cognition Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.21 Bn | -7.58 | 0.00 Mn | 0.17 Bn |
| 87 | NERV | Minerva Neurosciences, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.20 Bn | -31.04 | — | 0.20 Bn |
| 88 | MCUJF | Medicure Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.20 Bn | -38.69 | 0.00 Mn | 0.19 Bn |
| 89 | SLGL | Sol-Gel Technologies Ltd. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.19 Bn | -18.45 | 0.00 Mn | 0.15 Bn |
| 90 | CRDL | Cardiol Therapeutics Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.19 Bn | -7.34 | — | 0.19 Bn |
| 91 | LONA | LeonaBio, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.19 Bn | -1.55 | — | 0.14 Bn |
| 92 | LENZ | LENZ Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.17 Bn | -1.30 | 0.00 Mn | 0.17 Bn |
| 93 | MENS | Jyong Biotech Ltd. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.16 Bn | -46.69 | — | 0.16 Bn |
| 94 | BMEA | Biomea Fusion, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.14 Bn | -2.51 | — | 0.14 Bn |
| 95 | VANI | Vivani Medical, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.12 Bn | -4.38 | — | 0.10 Bn |
| 96 | AARD | Aardvark Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.12 Bn | -1.65 | — | 0.04 Bn |
| 97 | VRCA | Verrica Pharmaceuticals Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.11 Bn | -3.59 | 0.00 Mn | 0.10 Bn |
| 98 | NTHI | Neonc Technologies Holdings, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.10 Bn | -2.28 | — | 0.10 Bn |
| 99 | CPIX | Cumberland Pharmaceuticals Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.10 Bn | -9.28 | 0.00 Mn | 0.10 Bn |
| 100 | CGTX | Cognition Therapeutics Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.09 Bn | -2.50 | — | 0.09 Bn |
| 101 | TENX | Tenax Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.09 Bn | -1.38 | — | 0.09 Bn |
| 102 | RGC | Regencell Bioscience Holdings Ltd | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.09 Bn | — | — | 0.09 Bn |
| 103 | PTHS | Pelthos Therapeutics Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.09 Bn | -0.78 | 0.00 Mn | 0.06 Bn |
| 104 | MNOV | Medicinova Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.09 Bn | -7.50 | 0.00 Mn | 0.09 Bn |
| 105 | PMVP | PMV Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.07 Bn | -1.18 | — | -0.01 Bn |
| 106 | PLRX | Pliant Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.07 Bn | -0.77 | — | 0.07 Bn |
| 107 | CING | Cingulate Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.07 Bn | -3.20 | — | 0.07 Bn |
| 108 | BOLD | Boundless Bio, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.06 Bn | -1.00 | — | 0.06 Bn |
| 109 | VERU | Veru Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.06 Bn | 117.60 | — | 0.03 Bn |
| 110 | GOSS | Gossamer Bio, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.06 Bn | -0.33 | 0.00 Mn | 0.00 Bn |
| 111 | KPTI | Karyopharm Therapeutics Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.05 Bn | -0.25 | 0.00 Mn | -0.01 Bn |
| 112 | ANVS | Annovis Bio, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.05 Bn | -1.00 | — | 0.05 Bn |
| 113 | CLNN | Clene Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.05 Bn | -1.36 | 0.00 Mn | 0.05 Bn |
| 114 | APRE | Aprea Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.05 Bn | -3.63 | — | 0.05 Bn |
| 115 | IXHL | Incannex Healthcare Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -0.86 | — | 0.04 Bn |
| 116 | SCLX | Scilex Holding Co | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -0.08 | 0.00 Mn | -0.08 Bn |
| 117 | GRCE | Grace Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -1.83 | — | 0.04 Bn |
| 118 | CPHI | China Pharma Holdings, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -7.54 | 0.00 Mn | 0.03 Bn |
| 119 | UG | United Guardian Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | 14.46 | 0.00 Mn | 0.02 Bn |
| 120 | ACTU | Actuate Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -1.57 | — | 0.03 Bn |
| 121 | NSRX | Nasus Pharma Ltd | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -5.64 | — | 0.03 Bn |
| 122 | CRVO | CervoMed Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -0.85 | 0.00 Mn | 0.03 Bn |
| 123 | BYSI | BeyondSpring Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -3.02 | — | 0.03 Bn |
| 124 | TXMD | TherapeuticsMD, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -135.13 | 0.00 Mn | 0.02 Bn |
| 125 | YARW | Yarrow Bioscience, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -1.19 | 0.00 Mn | 0.00 Bn |
| 126 | AYTU | Aytu Biopharma, Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.76 | 0.00 Mn | 0.00 Bn |
| 127 | ATOS | Atossa Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.74 | — | 0.02 Bn |
| 128 | BFRI | Biofrontera Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -4.31 | 0.00 Mn | 0.02 Bn |
| 129 | ALLR | Allarity Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -1.66 | 0.00 Mn | 0.02 Bn |
| 130 | MIRA | Mira Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.55 | — | 0.01 Bn |
| 131 | TVRD | Tvardi Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.69 | — | 0.02 Bn |
| 132 | ANEB | Anebulo Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -1.78 | — | 0.02 Bn |
| 133 | CTXR | Citius Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.34 | 0.00 Mn | 0.02 Bn |
| 134 | INTI | Inhibitor Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -4.72 | — | 0.02 Bn |
| 135 | KPRX | Kiora Pharmaceuticals Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -1.42 | — | 0.02 Bn |
| 136 | CURX | Curanex Pharmaceuticals Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.98 | — | 0.00 Bn |
| 137 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.81 | — | 0.01 Bn |
| 138 | CALC | CalciMedica, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.33 | 0.00 Mn | -0.01 Bn |
| 139 | ADXN | Addex Therapeutics Ltd. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | 0.05 | — | 0.01 Bn |
| 140 | ACXP | Acurx Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.81 | — | 0.01 Bn |
| 141 | TRAW | Traws Pharma, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.36 | — | 0.00 Bn |
| 142 | PCSA | Processa Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.43 | — | 0.01 Bn |
| 143 | PULM | Pulmatrix, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -1.22 | — | 0.00 Bn |
| 144 | TCRT | Alaunos Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.95 | 0.00 Mn | 0.00 Bn |
| 145 | BICX | BioCorRx Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -1.64 | 0.00 Mn | 0.00 Bn |
| 146 | CVKD | Cadrenal Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.30 | — | 0.00 Bn |
| 147 | CASIF | CASI Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.02 | 0.00 Mn | 0.00 Bn |
| 148 | SKVI | Skinvisible, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -2.25 | 0.00 Mn | 0.00 Bn |
| 149 | OGEN | Oragenics Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.22 | — | 0.00 Bn |
| 150 | UPC | Universe Pharmaceuticals INC | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | — | — | -1,490.23 Bn |
| 151 | CANF | Can-Fite BioPharma Ltd. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.19 | 0.00 Mn | -0.01 Bn |
| 152 | ENSC | Ensysce Biosciences, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | — | — | 0.00 Bn |
| 153 | MTNB | Matinas BioPharma Holdings, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.16 | — | 0.00 Bn |
| 154 | SPRC | SciSparc Ltd. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.05 | 0.00 Mn | 0.00 Bn |
| 155 | NCEL | NewcelX Ltd. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.06 | — | 0.00 Bn |
| 156 | GLMD | Galmed Pharmaceuticals Ltd. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | — | — | 0.00 Bn |
| 157 | JAGX | Jaguar Health, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.01 | 0.00 Mn | -0.01 Bn |
| 158 | GCAN | Trafalgar International, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -2.70 | — | 0.00 Bn |
| 159 | CDT | CDT Equity Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.01 | — | 0.00 Bn |
| 160 | SXTC | China SXT Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | 0.00 | 0.00 Mn | -0.03 Bn |
| 161 | CMND | Clearmind Medicine Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | 0.00 | — | -0.01 Bn |
| 162 | PG | PROCTER & GAMBLE Co | secondary | S-10 | Household and Personal Products | SG-05 | 340.14 Bn | 21.07 | 0.00 Mn | 330.19 Bn |
| 163 | TMO | Thermo Fisher Scientific Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 224.42 Bn | 31.88 | 0.00 Mn | 220.36 Bn |
| 164 | GILD | Gilead Sciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 181.86 Bn | -62.82 | 0.00 Mn | 178.68 Bn |
| 165 | VRTX | Vertex Pharmaceuticals Inc / Ma | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 134.18 Bn | 30.46 | 0.00 Mn | 126.32 Bn |
| 166 | INVUP | Investview, Inc. | secondary | T-64 | Technology Services | TG-11 | 47.89 Bn | -3,556.63 | 0.00 Mn | 47.89 Bn |
| 167 | TEVA | Teva Pharmaceutical Industries Ltd | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 42.90 Bn | 61.64 | 0.00 Mn | 39.25 Bn |
| 168 | ADM | Archer-Daniels-Midland Co | secondary | S-07 | Agribusiness | SG-03 | 41.00 Bn | 23.05 | 0.00 Mn | 31.42 Bn |
| 169 | KVUE | Kenvue Inc. | secondary | S-11 | Household and Personal Products | SG-05 | 35.40 Bn | 21.35 | 0.00 Mn | 34.29 Bn |
| 170 | KMB | Kimberly Clark Corp | secondary | S-11 | Household and Personal Products | SG-05 | 34.27 Bn | 19.30 | 0.00 Mn | 33.31 Bn |
| 171 | ALC | Alcon Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 34.18 Bn | 53.15 | 0.00 Mn | 32.72 Bn |
| 172 | ZTS | Zoetis Inc. | secondary | H-05 | Pharmaceuticals and Biotechnology | HG-01 | 30.85 Bn | 9.43 | 0.00 Mn | 29.17 Bn |
| 173 | GEHC | GE HealthCare Technologies Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 30.31 Bn | 14.78 | 0.00 Mn | 28.21 Bn |
| 174 | ROIV | Roivant Sciences Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 30.07 Bn | -20.26 | 0.00 Mn | 30.07 Bn |
| 175 | INSM | INSMED Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 27.20 Bn | -31.08 | 0.00 Mn | 26.04 Bn |
| 176 | WST | West Pharmaceutical Services Inc | secondary | H-07 | Medical Devices and Diagnostics | HG-02 | 23.85 Bn | 43.41 | 0.00 Mn | 23.42 Bn |
| 177 | CHD | Church & Dwight Co Inc /De/ | secondary | S-10 | Household and Personal Products | SG-05 | 22.88 Bn | 30.73 | 0.00 Mn | 22.63 Bn |
| 178 | IFF | International Flavors & Fragrances Inc | secondary | M-02 | Chemicals | MG-01 | 21.87 Bn | 74.91 | 0.00 Mn | 21.30 Bn |
| 179 | STE | STERIS plc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 21.39 Bn | 26.47 | 0.00 Mn | 20.91 Bn |
| 180 | VTRS | Viatris Inc | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 19.28 Bn | -46.95 | 0.00 Mn | 18.40 Bn |
| 181 | BWXT | BWX Technologies, Inc. | secondary | I-39 | Clean Energy Equipment | IG-10 | 14.74 Bn | 41.38 | 0.00 Mn | 14.13 Bn |
| 182 | CRL | Charles River Laboratories International, Inc. | secondary | H-11 | Pharma Services | HG-03 | 13.52 Bn | -56.86 | 0.00 Mn | 13.32 Bn |
| 183 | CLX | Clorox Co /De/ | secondary | S-10 | Household and Personal Products | SG-05 | 11.18 Bn | 18.61 | 0.00 Mn | 11.04 Bn |
| 184 | GKOS | GLAUKOS Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 10.87 Bn | -68.98 | 0.00 Mn | 10.75 Bn |
| 185 | PRAX | Praxis Precision Medicines, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 10.26 Bn | -26.89 | — | 9.50 Bn |
| 186 | RDY | Dr Reddys Laboratories Ltd | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 9.89 Bn | 784.14 | 0.00 Mn | 9.72 Bn |
| 187 | PODD | Insulet Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 9.84 Bn | 26.20 | 0.00 Mn | 9.30 Bn |
| 188 | CHWY | Chewy, Inc. | secondary | S-04 | Branded Foods | SG-02 | 9.63 Bn | 37.75 | 0.00 Mn | 9.11 Bn |
| 189 | IONS | Ionis Pharmaceuticals Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 9.36 Bn | -44.12 | 0.00 Mn | 7.31 Bn |
| 190 | CELH | Celsius Holdings, Inc. | secondary | S-03 | Beverages | SG-01 | 7.56 Bn | 126.03 | 0.00 Mn | 6.93 Bn |
| 191 | LNTH | Lantheus Holdings, Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 6.55 Bn | 23.79 | 0.00 Mn | 5.96 Bn |
| 192 | BLRX | BioLineRx Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 6.43 Bn | -718.44 | 0.00 Mn | 6.43 Bn |
| 193 | BLCO | Bausch & Lomb Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 6.35 Bn | -38.95 | 0.00 Mn | 5.97 Bn |
| 194 | LGND | Ligand Pharmaceuticals Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 5.76 Bn | 29.22 | 0.00 Mn | 4.41 Bn |
| 195 | AMRX | Amneal Pharmaceuticals, Inc. | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 5.45 Bn | 25.30 | 0.00 Mn | 5.32 Bn |
| 196 | GRFS | Grifols SA | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 5.28 Bn | 20.78 | 0.00 Mn | 4.12 Bn |
| 197 | ERAS | Erasca, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 5.07 Bn | -17.64 | — | 5.07 Bn |
| 198 | DNLI | Denali Therapeutics Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 4.14 Bn | -8.09 | 0.00 Mn | 4.14 Bn |
| 199 | TLX | Telix Pharmaceuticals Ltd | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 4.08 Bn | — | — | 3.78 Bn |
| 200 | BBWI | Bath & Body Works, Inc. | secondary | S-11 | Household and Personal Products | SG-05 | 4.05 Bn | 6.11 | 0.00 Mn | 3.25 Bn |
| 201 | RCUS | Arcus Biosciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 3.68 Bn | -7.99 | 0.00 Mn | 2.97 Bn |
| 202 | IPAR | Interparfums Inc | secondary | S-12 | Household and Personal Products | SG-05 | 3.62 Bn | 17.63 | 0.00 Mn | 3.40 Bn |
| 203 | IMNM | Immunome Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 3.04 Bn | -11.23 | 0.00 Mn | 2.52 Bn |
| 204 | NRIX | Nurix Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.90 Bn | -8.49 | 0.00 Mn | 2.45 Bn |
| 205 | ZLAB | Zai Lab Ltd | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.84 Bn | -15.09 | 0.00 Mn | 2.13 Bn |
| 206 | WDFC | Wd 40 Co | secondary | S-10 | Household and Personal Products | SG-05 | 2.72 Bn | 30.44 | 0.00 Mn | 2.66 Bn |
| 207 | SLS | SELLAS Life Sciences Group, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.64 Bn | -81.24 | — | 2.64 Bn |
| 208 | CURLF | Curaleaf Holdings, Inc. | secondary | S-09 | Tobacco and Cannabis | SG-04 | 2.62 Bn | -22.11 | 0.00 Mn | 2.53 Bn |
| 209 | BHC | Bausch Health Companies Inc. | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 2.41 Bn | -2.21 | 0.00 Mn | 0.58 Bn |
| 210 | BCRX | Biocryst Pharmaceuticals Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.30 Bn | -5.99 | 0.00 Mn | 1.95 Bn |
| 211 | BHVN | Biohaven Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.22 Bn | -3.79 | — | 1.96 Bn |
| 212 | FMS | Fresenius Medical Care AG | secondary | H-14 | Healthcare Providers | HG-04 | 2.18 Bn | 2.00 | 0.00 Mn | 0.35 Bn |
| 213 | ADMA | Adma Biologics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.18 Bn | 13.11 | 0.00 Mn | 2.04 Bn |
| 214 | ZBIO | Zenas BioPharma, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.08 Bn | -5.00 | 0.00 Mn | 2.08 Bn |
| 215 | PRGO | PERRIGO Co plc | secondary | S-11 | Household and Personal Products | SG-05 | 2.03 Bn | -1.17 | 0.00 Mn | 1.63 Bn |
| 216 | SPB | Spectrum Brands Holdings, Inc. | secondary | S-04 | Branded Foods | SG-02 | 2.02 Bn | 23.91 | 0.00 Mn | 1.77 Bn |
| 217 | EDU | New Oriental Education & Technology Group Inc. | secondary | D-28 | Consumer Services | DG-09 | 1.85 Bn | 2.21 | 0.00 Mn | -0.89 Bn |
| 218 | NVAX | Novavax Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.67 Bn | -6.73 | 0.00 Mn | 0.95 Bn |
| 219 | SCNI | Scinai Immunotherapeutics Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.58 Bn | -188.46 | 0.00 Mn | 1.58 Bn |
| 220 | AAPG | Ascentage Pharma Group International | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.54 Bn | -9.11 | 0.00 Mn | 1.26 Bn |
| 221 | RARE | Ultragenyx Pharmaceutical Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.52 Bn | -3.29 | 0.00 Mn | 1.23 Bn |
| 222 | ANIP | Ani Pharmaceuticals Inc | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 1.49 Bn | 13.82 | 0.00 Mn | 1.13 Bn |
| 223 | AVBP | ArriVent BioPharma, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.45 Bn | -8.84 | — | 1.45 Bn |
| 224 | NMAX | Newsmax Inc. | secondary | C-05 | Advertising and Media | CG-02 | 1.39 Bn | -17.45 | 0.00 Mn | 1.34 Bn |
| 225 | OMER | Omeros Corp | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.38 Bn | 80.72 | 0.00 Mn | 1.38 Bn |
| 226 | HLF | Herbalife Ltd. | secondary | S-11 | Household and Personal Products | SG-05 | 1.31 Bn | 5.16 | 0.00 Mn | 0.94 Bn |
| 227 | EPC | EDGEWELL PERSONAL CARE Co | secondary | S-11 | Household and Personal Products | SG-05 | 1.28 Bn | -18.53 | 0.00 Mn | 0.89 Bn |
| 228 | CRVS | Corvus Pharmaceuticals, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.28 Bn | -26.87 | — | 1.07 Bn |
| 229 | IART | Integra Lifesciences Holdings Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.25 Bn | -172.98 | 0.00 Mn | 0.98 Bn |
| 230 | MGTX | MeiraGTx Holdings plc | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 1.24 Bn | 7.51 | 0.00 Mn | 1.10 Bn |
| 231 | MRVI | Maravai Lifesciences Holdings, Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 1.06 Bn | -7.81 | 0.00 Mn | 0.99 Bn |
| 232 | RAJAF | TFA Therapeutics, Inc. | secondary | S-11 | Household and Personal Products | SG-05 | 1.02 Bn | — | 0.00 Mn | 1.02 Bn |
| 233 | AMPH | Amphastar Pharmaceuticals, Inc. | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 1.01 Bn | 12.05 | 0.00 Mn | 0.71 Bn |
| 234 | MNPR | Monopar Therapeutics | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.97 Bn | -70.09 | — | 0.92 Bn |
| 235 | QDEL | QuidelOrtho Corp | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.92 Bn | — | — | 0.79 Bn |
| 236 | ACRS | Aclaris Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.87 Bn | -10.88 | 0.00 Mn | 0.87 Bn |
| 237 | AVR | Anteris Technologies Global Corp. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.84 Bn | -10.16 | 0.00 Mn | 0.84 Bn |
| 238 | ODD | Oddity Tech Ltd | secondary | S-12 | Household and Personal Products | SG-05 | 0.75 Bn | 10.22 | 0.00 Mn | 0.45 Bn |
| 239 | HELE | Helen Of Troy Ltd | secondary | D-06 | Household Durables | DG-02 | 0.65 Bn | -1.57 | 0.00 Mn | 0.63 Bn |
| 240 | EVO | Evotec SE | secondary | H-11 | Pharma Services | HG-03 | 0.65 Bn | — | — | 0.22 Bn |
| 241 | HNST | Honest Company, Inc. | secondary | S-11 | Household and Personal Products | SG-05 | 0.64 Bn | -52.38 | 0.00 Mn | 0.53 Bn |
| 242 | OCS | Oculis Holding AG | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.63 Bn | -361,653.86 | — | 0.63 Bn |
| 243 | EVOH | EvoAir Holdings Inc. | secondary | I-14 | Construction Products | IG-03 | 0.63 Bn | -56.89 | 0.00 Mn | 0.62 Bn |
| 244 | BWMX | Betterware De Mexico, S.A.P.I. De C.V | secondary | S-12 | Household and Personal Products | SG-05 | 0.58 Bn | 10.20 | 0.00 Mn | 0.55 Bn |
| 245 | DCTH | Delcath Systems, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.58 Bn | 1,165.54 | 0.00 Mn | 0.48 Bn |
| 246 | PRLD | Prelude Therapeutics Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.52 Bn | -7.71 | 0.00 Mn | 0.24 Bn |
| 247 | ANL | Adlai Nortye Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.51 Bn | -10.27 | 0.00 Mn | 0.27 Bn |
| 248 | EVMN | Evommune, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.48 Bn | -5.02 | 0.00 Mn | 0.27 Bn |
| 249 | RGNX | REGENXBIO Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.46 Bn | -2.61 | 0.00 Mn | 0.36 Bn |
| 250 | IRD | Opus Genetics, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.42 Bn | -4.28 | 0.00 Mn | 0.33 Bn |
| 251 | EYPT | EyePoint, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.39 Bn | -1.26 | 0.00 Mn | 0.21 Bn |
| 252 | PRE | Prenetics Global Ltd | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.36 Bn | -7.61 | 0.00 Mn | 0.30 Bn |
| 253 | EMBC | Embecta Corp. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.32 Bn | 3.67 | 0.00 Mn | 0.10 Bn |
| 254 | STRO | Sutro Biopharma, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.32 Bn | -2.80 | 0.00 Mn | 0.15 Bn |
| 255 | SWKHL | SWK Holdings Corp | secondary | F-06 | Lending and Credit | FG-02 | 0.31 Bn | -332.63 | 0.00 Mn | 0.27 Bn |
| 256 | USNA | Usana Health Sciences Inc | secondary | S-11 | Household and Personal Products | SG-05 | 0.28 Bn | -9.72 | 0.00 Mn | 0.12 Bn |
| 257 | MGNX | Macrogenics Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.27 Bn | -17.05 | 0.00 Mn | 0.16 Bn |
| 258 | OSUR | Orasure Technologies Inc | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.25 Bn | — | 0.00 Mn | 0.05 Bn |
| 259 | NAGE | Niagen Bioscience, Inc. | secondary | S-11 | Household and Personal Products | SG-05 | 0.25 Bn | 15.45 | 0.00 Mn | 0.18 Bn |
| 260 | NATR | Natures Sunshine Products Inc | secondary | S-11 | Household and Personal Products | SG-05 | 0.25 Bn | 13.12 | 0.00 Mn | 0.16 Bn |
| 261 | NUS | Nu Skin Enterprises, Inc. | secondary | S-12 | Household and Personal Products | SG-05 | 0.23 Bn | -1.04 | 0.00 Mn | 0.04 Bn |
| 262 | FTH | Faeth Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.22 Bn | -1.14 | — | 0.22 Bn |
| 263 | UTMD | Utah Medical Products Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.22 Bn | 22.28 | 0.00 Mn | 0.13 Bn |
| 264 | PTNM | Pitanium Ltd | secondary | S-12 | Household and Personal Products | SG-05 | 0.21 Bn | -63.51 | 0.00 Mn | -2.70 Bn |
| 265 | BFNH | Bioforce Nanosciences Holdings, Inc. | secondary | S-11 | Household and Personal Products | SG-05 | 0.21 Bn | -2,020.67 | — | 0.21 Bn |
| 266 | WALD | Waldencast plc | secondary | S-12 | Household and Personal Products | SG-05 | 0.15 Bn | -1.75 | 0.00 Mn | 0.12 Bn |
| 267 | IFRX | InflaRx N.V. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.15 Bn | 0.00 | 0.00 Mn | -0.04 Bn |
| 268 | TNYA | Tenaya Therapeutics, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.14 Bn | -1.40 | 0.00 Mn | 0.14 Bn |
| 269 | SPRB | Spruce Biosciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.14 Bn | -2.99 | — | 0.14 Bn |
| 270 | MED | Medifast Inc | secondary | S-11 | Household and Personal Products | SG-05 | 0.14 Bn | -5.29 | 0.00 Mn | -0.03 Bn |
| 271 | APYX | Apyx Medical Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.13 Bn | -15.52 | 0.00 Mn | 0.11 Bn |
| 272 | CDXS | Codexis, Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 0.13 Bn | -4.28 | 0.00 Mn | 0.08 Bn |
| 273 | PYPD | PolyPid Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.09 Bn | 2.77 | — | 0.08 Bn |
| 274 | FBIO | Fortress Biotech, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.09 Bn | 10.29 | 0.00 Mn | -0.11 Bn |
| 275 | LFVN | Lifevantage Corp | secondary | S-11 | Household and Personal Products | SG-05 | 0.08 Bn | 16.71 | 0.00 Mn | 0.07 Bn |
| 276 | NTRB | NutriBand Inc. | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.07 Bn | -10.39 | 0.00 Mn | 0.07 Bn |
| 277 | AIFC | AI Financial Corp | secondary | T-54 | Fintech | TG-09 | 0.07 Bn | -0.09 | 0.00 Mn | 0.07 Bn |
| 278 | GWLL | Goldenwell Biotech, Inc. | secondary | S-11 | Household and Personal Products | SG-05 | 0.07 Bn | -574.97 | 1.26 Mn | 0.07 Bn |
| 279 | UPXI | Upexi, Inc. | secondary | T-59 | Fintech | TG-09 | 0.07 Bn | -0.28 | 0.00 Mn | 0.06 Bn |
| 280 | XBIT | XBiotech Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.07 Bn | -1.61 | — | 0.07 Bn |
| 281 | CWBHF | Charlotte's Web Holdings, Inc. | secondary | S-09 | Tobacco and Cannabis | SG-04 | 0.07 Bn | -1.90 | 0.00 Mn | 0.05 Bn |
| 282 | HAIN | Hain Celestial Group Inc | secondary | S-04 | Branded Foods | SG-02 | 0.06 Bn | -0.16 | 0.00 Mn | 0.02 Bn |
| 283 | HYFT | MindWalk Holdings Corp. | secondary | H-11 | Pharma Services | HG-03 | 0.06 Bn | -5.81 | 0.00 Mn | 0.05 Bn |
| 284 | IBO | Impact Biomedical Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.05 Bn | -2.88 | 0.00 Mn | 0.05 Bn |
| 285 | LEEEF | Leef Brands Inc. | secondary | S-09 | Tobacco and Cannabis | SG-04 | 0.05 Bn | -11.75 | 0.00 Mn | 0.05 Bn |
| 286 | PTN | Palatin Technologies Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.05 Bn | -7.76 | 0.00 Mn | 0.05 Bn |
| 287 | ABLV | Able View Global Inc. | secondary | S-12 | Household and Personal Products | SG-05 | 0.05 Bn | 13.49 | 0.00 Mn | 0.04 Bn |
| 288 | GROV | Grove Collaborative Holdings, Inc. | secondary | S-10 | Household and Personal Products | SG-05 | 0.04 Bn | -5.49 | 0.00 Mn | 0.03 Bn |
| 289 | LSF | Laird Superfood, Inc. | secondary | S-03 | Beverages | SG-01 | 0.04 Bn | -8.09 | 0.00 Mn | 0.02 Bn |
| 290 | BTMD | biote Corp. | secondary | H-14 | Healthcare Providers | HG-04 | 0.04 Bn | 6.63 | 0.00 Mn | 0.03 Bn |
| 291 | BODI | Beachbody Company, Inc. | secondary | T-48 | Internet Platforms | TG-08 | 0.04 Bn | — | — | 0.00 Bn |
| 292 | APLM | Apollomics Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -3.72 | 0.00 Mn | 0.04 Bn |
| 293 | CELU | Celularity Inc | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -0.43 | 0.00 Mn | 0.03 Bn |
| 294 | PETS | Petmed Express Inc | secondary | S-14 | Staples Retail | SG-06 | 0.04 Bn | -1.32 | 0.00 Mn | 0.03 Bn |
| 295 | LASE | Laser Photonics Corp | secondary | I-04 | Machinery | IG-02 | 0.04 Bn | -1.03 | 0.00 Mn | 0.04 Bn |
| 296 | BHST | Bioharvest Sciences Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -3.14 | 0.00 Mn | 0.02 Bn |
| 297 | KAPA | Kairos Pharma, LTD. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -6.19 | 0.00 Mn | 0.03 Bn |
| 298 | NSYS | Nortech Systems Inc | secondary | I-04 | Machinery | IG-02 | 0.03 Bn | 12.07 | 0.00 Mn | 0.03 Bn |
| 299 | BETRF | BetterLife Pharma Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -21.42 | — | 0.03 Bn |
| 300 | HAFG | Holistic Asset Finance Group Co., Ltd. | secondary | C-04 | Advertising and Media | CG-02 | 0.03 Bn | -269.75 | 0.00 Mn | 0.03 Bn |